Flt3 Receptor Tyrosine Kinase as a Drug Target in Leukemia
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
1867-1883
Author(s):
Dirk Schmidt-Arras, Joachim Schwable, Frank- D. Bohmer and Hubert Serve
The Role of Protein Kinase C-alpha (PKC-α) in Cancer and its Modulation by the Novel PKC-α-Specific Inhibitor Aprinocarsen
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
1923-1936
Author(s):
A- R. Hanauske, Karen Sundell and Michael Lahn
SRC: Regulation, Role in Human Carcinogenesis and Pharmacological Inhibitors
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
1745-1756
Author(s):
A. Y. Tsygankov and S. K. Shore
Therapeutic Potential of Janus Kinase 3 (JAK3) Inhibitors
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
1767-1784
Author(s):
M. Cetkovic-Cvrlje and H. E. Tibbles
Signaling Pathways Responsible for Cancer Cell Invasion as Targets for Cancer Therapy
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
327-336
Author(s):
Daniel Sliva
Thymidylate Synthase Gene in Pharmacogenetics
Journal:
Current Pharmacogenomics
Volume:
2
Page:
137-147
Author(s):
Kazuyuki Kawakami
Immune Deviation Strategies in the Therapy of Psoriasis
Journal:
Current Drug Targets - Inflammation & Allergy
Volume:
3
Page:
193-198
Author(s):
Kamran Ghoreschi and Martin Rocken
The Akt Pathway: Molecular Targets for Anti-Cancer Drug Development
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
235-256
Author(s):
Constantine S. Mitsiades, Nicholas Mitsiades and Michael Koutsilieris
Retinoids in Cancer Chemoprevention
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
285-298
Author(s):
Masataka Okuno, Soichi Kojima, Rie Matsushima-Nishiwaki, Hisashi Tsurumi, Yasutoshi Muto, Scott L. Friedman and Hisataka Moriwaki
Emerging Concepts in the Analysis of Mitochondrial Genome Instability
Journal:
Current Genomics
Volume:
5
Page:
309-325
Author(s):
Raphael Saffroy, Franck Chiappini, Brigitte Debuire and Antoinette Lemoine